TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/22 16:43 | 10/4/22 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hilzinger Kurt J | NJ | D | P.m | 143 | 1.28 | 0 | 111 | 31 | 473 | D | |||||||||||||||
10/3/22 17:19 | 9/29/22 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hilzinger Kurt J | NJ | D | P.m | 111 | 1.24 | 0 | 89 | 33 | 362 | D | |||||||||||||||
3/3/22 17:30 | 3/1/22 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hilzinger Kurt J | NJ | D | P | 47 | 1.69 | 0 | 28 | 11 | 273 | D | |||||||||||||||
2/28/22 17:57 | 2/24/22 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hilzinger Kurt J | NJ | D | P.m | 70 | 1.48 | 0 | 47 | 24 | 245 | D | |||||||||||||||
2/23/22 17:42 | 2/22/22 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hilzinger Kurt J | NJ | D | P.m | 257 | 1.47 | 0 | 175 | 758 | 198 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |